Sonoma Pharmaceuticals, Inc. 8-K Filing Summary

Sonoma Pharmaceuticals, Inc. has entered into a Manufacturing and Supply Agreement with Kenvue Brands LLC. This agreement, effective from October 24, 2025, through March 2027, with potential for two additional one-year extensions, covers the sale of Microcyn® technology-based products within the United States. The agreement details various aspects of the supply chain, including product pricing, raw material sourcing, order fulfillment, and quality control. It specifies that Kenvue Brands LLC will be the buyer and Sonoma Pharmaceuticals, Inc. will be the manufacturer. The agreement also outlines terms for product improvements, termination conditions, and the responsibilities of both parties regarding intellectual property rights and regulatory compliance. The filing includes exhibits such as the agreement itself and an interactive data file.